Myrexis, Inc.

Myrexis, Inc.

MYRX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$23.92K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Myrexis, Inc.Myrexis, Inc.0--999%-0.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$23,918.00
Enterprise Value$-1,037,082.00
Earnings per Share$-0.39
Beta3.18
Outstanding Shares29,897,000

Return

Return on Equity-999.23%ROE
Return on Assets-939.45%
Return on Invested Capital-1062.68%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0.08
Enterprise Value to Net Income0
Total Debt to Enterprise-0.07
Debt to Equity0.06Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Myrexis, Inc.

1 employees
CEO: Jonathan Couchman

Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceutical...